SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-009986
Filing Date
2023-03-27
Accepted
2023-03-27 16:06:20
Documents
5
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 PRE 14A gelesis_-_pre_14a.htm PRE 14A 1235268
2 GRAPHIC img138478231_0.jpg GRAPHIC 4540
3 GRAPHIC img138478231_1.jpg GRAPHIC 4540
4 GRAPHIC img138478231_2.jpg GRAPHIC 50085
5 GRAPHIC img138478231_3.jpg GRAPHIC 55261
  Complete submission text file 0000950170-23-009986.txt   1394545
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39362 | Film No.: 23764581
SIC: 2834 Pharmaceutical Preparations